Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells
Our understanding of the hierarchical structure of acute leukemia has yet to be fully translated into therapeutic approaches. Indeed, chemotherapy still has to take into account the possibility that leukemia-initiating cells may have a distinct chemosensitivity profile compared to the bulk of the tu...
Enregistré dans:
Auteurs principaux: | Vincent Fregona, Manon Bayet, Bastien Gerby |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fba48e79826043c6a263d7d90bb21e71 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Profound leukemia cutis in a patient with relapsed T-cell acute lymphoblastic leukemia
par: Ambika Nohria, BA, et autres
Publié: (2021) -
Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study
par: Dong Won Baek, et autres
Publié: (2021) -
Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted Immunotherapy
par: Franquiz MJ, et autres
Publié: (2020) -
T-Cell Acute Lymphoblastic Leukemia—Current Concepts in Molecular Biology and Management
par: Parveen Shiraz, et autres
Publié: (2021) -
STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
par: O. V. Smirnova, et autres
Publié: (2014)